financetom
Economy
financetom
/
Economy
/
GST council to consider exemption of cancer drug from IGST
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GST council to consider exemption of cancer drug from IGST
Jul 7, 2023 8:52 AM

The GST Council at its next meeting on Tuesday, July 11, is likely to exempt cancer medicine Dinutuximab from tax. The drug, branded as Qarziba, is used to treat Neuroblastoma, a cancer of nerve cells in patients over 1 year of age.

Share Market Live

NSE

The drug worth Rs 36 lakh, is imported by individuals for personal use. It is currently taxed as at rate of 12 percent IGST. Opinion is that the medicine should be exempted from GST as the drug is expensive and money to fund treatment is generally through crowdfunding.

The parliamentary panel, last year, recommended waiving GST on cancer drugs. The panel pointed out that cancer treatment is expensive in the country and should be a notifiable disease. That means, it is required by law and information is reported to the government.

Experts point out that when it comes to patented or rare disease drugs, majority of the time the drugs are imported. Patient generally have to raise the funds on their own unless they are part of a charity program. Patients generally resort to crowd funding and donations. This is piecemeal as patients don’t always manage to raise funds.

The other option is filing a PIL to try and have the government support the patient via its rare diseases fund. While many of the times these options are effective, the process can run into months and many a times the administering of the drug is time sensitive.

Besides being expensive access to many of these rare disease and patented drugs is also unregulated and erratic. They are mostly imported that too on a need basis. Generally, when a drug is prescribed by a doctor, the patient is connected to either an NGO that helps facilitate the process or other patients that need the drug. The end goal, being a distributor, will import the drug generally for a group of patients.

Lawyers say pharma companies want to steer clear of manufacturing cheaper copies in the country due to the heavy patenting hence possibility of litigation.

The issue, experts say, has to be taken up at a government level to improve accessibility and options to reduce pricing such as compulsory licensing, raising the government funds for rare diseases and urging companies to adopt patients via CSR programs. ​

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US small business sentiment up in May, but looming election clouds outlook
US small business sentiment up in May, but looming election clouds outlook
Jun 11, 2024
(Reuters) - U.S. small-business confidence and hiring plans increased in May to their highest levels of the year, but the looming U.S. presidential election also drove uncertainty to nearly a four-year high, a survey showed on Tuesday. The National Federation of Independent Business (NFIB) said its Small Business Optimism Index rose eight-tenths of a point to 90.5 last month, the...
US small business sentiment up in May, but looming election clouds outlook
US small business sentiment up in May, but looming election clouds outlook
Jun 11, 2024
(Reuters) - U.S. small-business confidence and hiring plans increased in May to their highest levels of the year, but the looming U.S. presidential election also drove uncertainty to nearly a four-year high, a survey showed on Tuesday. The National Federation of Independent Business (NFIB) said its Small Business Optimism Index rose eight-tenths of a point to 90.5 last month, the...
US Dollar Rises in Europe as Risk Assets Soften into Wednesday's US CPI, Fed Decision
US Dollar Rises in Europe as Risk Assets Soften into Wednesday's US CPI, Fed Decision
Jun 11, 2024
06:16 AM EDT, 06/11/2024 (MT Newswires) -- US dollar exchange rates rose broadly during early European trade on Tuesday as risky assets softened almost across the board ahead of eagerly awaited updates on US inflation and Fed policy slated for Wednesday. The US dollar rose against all counterparts in the G10 basket except for the Swiss franc and British pound...
US Dollar Rises Early Tuesday Ahead of Redbook Retail Sales
US Dollar Rises Early Tuesday Ahead of Redbook Retail Sales
Jun 11, 2024
07:45 AM EDT, 06/11/2024 (MT Newswires) -- The US dollar rose against its major trading partners early Tuesday, except for a decline versus the pound, before a light data schedule. Earlier Tuesday, the National Federation of Independent Business reported that small business optimism improved in May to the highest level so far in 2024, but inflation and labor quality remain...
Copyright 2023-2025 - www.financetom.com All Rights Reserved